NewslettersCell Therapy NewsUncategorizedPeripheral Leukemia Burden at Time of Apheresis Negatively Affects the Clinical Efficacy of CART19 in Refractory or Relapsed B-ALLBy Justin.choi - November 1, 2021099Scientists retrospectively analyzed 143 patients treated with CART19 to evaluate the effect of peripheral leukemia burden at time of apheresis.[Molecular Therapy-Methods & Clinical Development] 6445212 AAAAAAAA items 1 apa 0 default asc 1 168434 https://www.stemcellsciencenews.com/wp-content/plugins/zotpress/AbstractFull ArticleGraphical Abstract